Stock Analiz

SciSparc Ltd. SPRC

Biotechnology: Pharmaceutical Preparations · data as of November 13, 2026

$0.35Market cap $869843
Open the interactive analysis →

SciSparc Ltd. (SPRC) is a healthcare company listed in the US with a market value of about $869843. In fiscal year 2024 it had revenue of $1M and net income of -$6M, a net margin of -481.2%.

Its overall Stock Analiz score is 1.0 out of 5 (weak). The strongest part is financial health (4/5); the weakest is value (0/5).

Key numbers: a 5-year average ROIC of -100%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 74% below the current price.

About SciSparc

SciSparc is listed in the US and classified in biotechnology: pharmaceutical preparations. It was profitable in 1 of the last 10 years in our data.

Score: 1.0 / 5

Value0/5
Future growth0/5
Track record1/5
Financial health4/5
Shareholder returns0/5

Checks passed

  • 5-year EPS growth above 10% a year
  • More cash than debt, or low debt to equity
  • Interest covered more than 5 times
  • Debt below 3 years of free cash flow
  • Liabilities below 60% of assets

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • Profit margin improving

Valuation

P/E (TTM)—
Forward P/E—
P/FCF—
P/S0.7
P/B0.1
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield—
Shareholder yield0.0%
Intrinsic value vs. price−74%

Growth and quality

Revenue growth (1 yr)-54.6%
Revenue growth (5 yrs, per year)—
EPS growth (5 yrs, per year)14.9%
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-283.8%
ROIC (5-yr avg.)-99.9%
Profitable years (of last 10)1
Years paying a dividend—

Financials, last 10 years

Fiscal year2024202320222021202020192018201720162015
Revenue$1M$3M$1M———————
Net income-$6M-$5M-$3M-$6M-$4M-$5M-$9M-$6M-$2M$3M
Free cash flow——-$8M-$5M—-$5M-$7M-$5M-$1M-$1M
EPS (diluted)$-2.55$-2.08$-1.05$-2.35$-1.44$-1.90$-3.63$-2.53$-0.81$1.03
Net margin-481.2%-177.9%-192.4%———————
ROIC-89.6%-70.7%-101.5%-56.0%-181.9%-23180.9%-3888.0%-54.2%-275.7%175.4%

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

Is SciSparc stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 74% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does SciSparc pay a dividend?

Not currently.

Is SciSparc a good stock to buy?

We do not give buy or sell advice. SciSparc scores 1.0 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.